META vs. VRTX
META (Meta Platforms, Inc.) and VRTX (Vertex Pharmaceuticals Incorporated) are both stocks. META operates in Internet Content & Information (Communication Services), while VRTX operates in Biotechnology (Healthcare). Over the past 10 years, META returned 17.39%/yr vs 17.15%/yr for VRTX. At a 0.32 correlation, their price movements are largely independent.
Performance
META vs. VRTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, META achieves a -14.03% return, which is significantly lower than VRTX's -1.86% return. Both investments have delivered pretty close results over the past 10 years, with META having a 17.39% annualized return and VRTX not far behind at 17.15%.
META
- 1D
- -0.26%
- 1M
- -8.32%
- YTD
- -14.03%
- 6M
- -11.84%
- 1Y
- -16.71%
- 3Y*
- 28.18%
- 5Y*
- 11.52%
- 10Y*
- 17.39%
VRTX
- 1D
- -0.03%
- 1M
- -1.22%
- YTD
- -1.86%
- 6M
- -1.57%
- 1Y
- -2.31%
- 3Y*
- 9.16%
- 5Y*
- 18.18%
- 10Y*
- 17.15%
META vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
META Meta Platforms, Inc. | -14.03% | 13.09% | 66.05% | 194.13% | -64.22% | 23.13% | 33.09% | 56.57% | -25.71% | 53.38% |
VRTX Vertex Pharmaceuticals Incorporated | -1.86% | 12.58% | -1.03% | 40.90% | 31.50% | -7.08% | 7.94% | 32.13% | 10.58% | 103.42% |
Correlation
The correlation between META and VRTX is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.23 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.31 |
Correlation (All Time) Calculated using the full available price history since May 18, 2012 | 0.32 |
The correlation between META and VRTX shifts across timeframes, from 0.12 (1 year) to 0.32 (all time), reflecting how their relationship changes across market environments.
Fundamentals
META:
$1.45T
VRTX:
$114.03B
META:
$27.47
VRTX:
$16.87
META:
20.64
VRTX:
26.38
META:
0.85
VRTX:
2.19
META:
6.78
VRTX:
9.34
META:
5.97
VRTX:
4.31
META:
$214.96B
VRTX:
$12.26B
META:
$176.14B
VRTX:
$10.57B
META:
$106.31B
VRTX:
$5.19B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
META vs. VRTX — Risk / Return Rank
META
VRTX
META vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Meta Platforms, Inc. (META) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| META | VRTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.41 | ||
| Sortino ratioReturn per unit of downside risk | -0.65 | ||
| Omega ratioGain probability vs. loss probability | 0.93 | 1.02 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | -0.54 | -0.14 | -0.40 |
| Martin ratioReturn relative to average drawdown | -1.12 | -0.29 | -0.83 |
Loading charts...
Drawdowns
META vs. VRTX - Drawdown Comparison
The maximum META drawdown since its inception was -76.74%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for META and VRTX.
Loading charts...
Drawdown Indicators
| META | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.74% | -91.77% | +15.03% |
Max Drawdown (1Y)Largest decline over 1 year | -33.30% | -23.56% | -9.74% |
Max Drawdown (3Y)Largest decline over 3 years | -34.15% | -29.07% | -5.08% |
Max Drawdown (5Y)Largest decline over 5 years | -76.74% | -29.07% | -47.67% |
Max Drawdown (10Y)Largest decline over 10 years | -76.74% | -41.60% | -35.14% |
Current DrawdownCurrent decline from peak | -28.06% | -13.90% | -14.16% |
Average DrawdownAverage peak-to-trough decline | -15.83% | -37.73% | +21.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.06% | 11.30% | +4.76% |
Volatility
META vs. VRTX - Volatility Comparison
Meta Platforms, Inc. (META) has a higher volatility of 10.17% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.47%. This indicates that META's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| META | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.17% | 7.47% | +2.70% |
Volatility (6M)Calculated over the trailing 6-month period | 26.91% | 20.71% | +6.20% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.52% | 34.13% | +1.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.04% | 28.53% | +15.51% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.67% | 32.82% | +5.85% |
Dividends
META vs. VRTX - Dividend Comparison
META's dividend yield for the trailing twelve months is around 0.37%, while VRTX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
META Meta Platforms, Inc. | 0.37% | 0.32% | 0.34% |
VRTX Vertex Pharmaceuticals Incorporated | 0.00% | 0.00% | 0.00% |
Financials
META vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between Meta Platforms, Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
META vs. VRTX - Profitability Comparison
META - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a gross profit of 46.09B and revenue of 56.31B. Therefore, the gross margin over that period was 81.9%.
VRTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a gross profit of 2.59B and revenue of 2.99B. Therefore, the gross margin over that period was 86.9%.
META - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported an operating income of 22.87B and revenue of 56.31B, resulting in an operating margin of 40.6%.
VRTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported an operating income of 1.14B and revenue of 2.99B, resulting in an operating margin of 38.1%.
META - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Meta Platforms, Inc. reported a net income of 26.77B and revenue of 56.31B, resulting in a net margin of 47.5%.
VRTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vertex Pharmaceuticals Incorporated reported a net income of 1.03B and revenue of 2.99B, resulting in a net margin of 34.5%.
Frequently Asked Questions
META and VRTX have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
META has higher volatility (10.17%) compared to VRTX (7.47%). In terms of maximum drawdown, META dropped -76.74% vs VRTX's -91.77%.
VRTX currently has the higher Sharpe Ratio (-0.10 vs -0.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for META and VRTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer